A Clinical Trial to Investigate the Influence of CES1 Polymorphism on Oseltamivir

NCT01902342 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Healthy

Interventions

DRUG: Oseltamivir 75 mg 1 cap

Sponsor

Seoul National University Hospital